CorMedix Stock Price

0.0936 (2.21%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data!
Ultimate Trader (Monthly)
Monthly Subscription
for only
Small Cap Basic
Monthly Subscription
for only
Big Cap Pro
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
CorMedix Inc CRMD AMEX Common Stock
  Price Change Change Percent Stock Price Low Price High Price Open Price Previous Close Last Traded
0.0936 2.21% 4.3336 4.23 4.45 4.40 4.24 12:38:50
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
808 175,572 $ 4.33 $ 760,276 410,574 2.00 - 9.23
Last Trade Time Type Quantity Stock Price Currency
12:38:50 200 $ 4.3336 USD

CorMedix Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 113.22M 26.13M 25.56M $ 283.27k $ - -1.78 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
4.16M $ - 0.00% - -

more financials information »

CorMedix News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CRMD Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week4.704.87734.004.41435,906-0.3664-7.8%
1 Month6.106.954.005.19489,209-1.77-28.96%
3 Months3.817.573.475.33318,9440.523613.74%
6 Months6.647.572.004.79287,032-2.31-34.73%
1 Year9.,483-4.77-52.38%
3 Years1.9513.700.86054.981,435,7782.38122.24%
5 Years17.5522.700.86055.61994,857-13.22-75.31%

CorMedix Description

Cormedix Inc is a biopharmaceutical company which focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It has in-licensed to develop and commercialize Neutrolin, which is a novel anti-infective solution or the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings such as dialysis, critical/intensive care, and oncology. The Neutrolin product is designed to target unmet medical need.

Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.